Literature DB >> 29255835

Curcumin Micelles Improve Mitochondrial Function in a Mouse Model of Alzheimer's Disease.

S Hagl1, M Heinrich, A Kocher, C Schiborr, J Frank, G P Eckert.   

Abstract

Preventive strategies for late-onset Alzheimer's disease (AD) should start early at a prodromal stage. Mitochondrial dysfunction has been found to play an important role in the initiation of both aging and the pathogenesis of Alzheimer's disease. Curcumin, a widely used spice and food-coloring agent, is a polyphenol derived from the rhizome of Curcuma longa. It is known to have anti-oxidant, anti-inflammatory, and anti-protein-aggregate activities which are usually considered beneficial for mitochondrial function. We assessed brain mitochondrial function and concentrations of soluble Aβ40 in a mouse model of AD (Thy1-APP751SL transgenic mice) after 3-week administration of curcumin micelles. Curcumin micelles are a newly developed formulation that account for increased curcumin bioavailability. Curcumin treatment had positive effects on mitochondrial membrane potential and respiratory control ratio. Additionally, it decreased levels of soluble Aβ40 in brains of Thy1-APPSL transgenic mice. Hence, curcumin micelles are a promising neutraceutical for the prevention of AD.

Entities:  

Keywords:  Alzheimer; Curcumin zzm321990; bioavailabilityzzm321990; mitochondria; prevention

Year:  2014        PMID: 29255835     DOI: 10.14283/jpad.2014.2

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  4 in total

1.  Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease.

Authors:  Ankit Parikh; Krishna Kathawala; Jintao Li; Chi Chen; Zhengnan Shan; Xia Cao; Xin-Fu Zhou; Sanjay Garg
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Anti-inflammatory effects of bone marrow mesenchymal stem cells on mice with Alzheimer's disease.

Authors:  Yan Wei; Zhaohong Xie; Jianzhong Bi; Zhengyu Zhu
Journal:  Exp Ther Med       Date:  2018-10-12       Impact factor: 2.447

Review 3.  Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.

Authors:  Chanchal Sharma; Sehwan Kim; Youngpyo Nam; Un Ju Jung; Sang Ryong Kim
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 4.  Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update.

Authors:  Giovanna Cenini; Wolfgang Voos
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.